²é¿´: 1469  |  »Ø¸´: 1

Ò»Íë²ÝÍ·

гæ (³õÈëÎÄ̳)

[ÇóÖú] ¡¾ÇóÖú¡¿ÎÒͶµÄplos oneµÚ¶þ´Î»ØÐÅ»¹ÊÇÒªÇóµÀµÂÉùÃ÷£¬ÇóÖú£¡

2014Äê4Ô±¾È˵ÚÒ»´ÎͶÁËplos one£¬È»ºóÓÉÓÚȱ·¦¾­Ñ飬µÚÒ»´ÎÍüÁËÎÄÕÂÖк¬ÓÐ×éÖ¯Ñù±¾£¬ËùÒÔµÚÒ»´ÎûÓмÓEthics Statement¡£È»ºóÊÕµ½¸ñʽµÄ»ØÐÅÈçÏ£º
1. Thank you for including your ethics statement on the online submission form: "The study was approved by the Institutional Review Board of the School of Life Sciences of Soochow University. And all participants had signed a written informed consent for donating their biological samples."To help ensure that the wording of your manuscript is suitable for publication, would you please also add this statement at the beginning of the Methods section of your manuscript file.2. We require information about the tissue sources for all previously unpublished, de novo cell lines. Please provide details of institutional review board or ethics committee approval (including the specific name of the board/committee) and confirmation of written informed consent (if human cell lines) for the collection and generation of the cell lines described. Where the lines are previously published a reference may be sufficient. Once you have included this statement in the Methods section of your main article file, please also amend the manuscript submission form (via Edit Submission) to include this ethics statement in the appropriate box.È»ºó²¹ÁËEthics Statement£¬²¢ÇÒÉÏ´«ÍêºóÏÂÔØpdfÈ·ÈÏÓУ¬µÈÁËÒ»¸öÔÂÓÐÊÕµ½ÀàËÆµÄÓʼþ£º
1. Thank you for stating in the methods: "Mouse pituitary epithelial-like tumor ATT20 cells were grown to 80% confluence in Dulbecco¡¯s modified Eagle¡¯s medium (DMEM) supplemented with 10% fetal calf serum (FCS) 2 mM glutamine,10 mM HEPES buffer, and penicillin-streptomycin (100 IU/ml; 100 g/ml) at 37¡ãC in a humid atmosphere (5%CO2). All culture reagents were purchased from the American Type Cell Collection (ATCC, Manassas, VA)"We require information about the tissue sources for all previously unpublished, de novo cell lines. Please provide details of institutional review board or ethics committee approval (including the specific name of the board/committee) and confirmation of written informed consent (if human cell lines) for the collection and generation of the cell lines described. Where the lines are previously published a reference may be sufficient. Once you have included this statement in the Methods section of your main article file, please also amend the manuscript submission form (via Edit Submission) to include this ethics statement in the appropriate box.Õâ¸öϸ°ûϵÊÇСÊóµÄ¶øÇÒÊÇ´ÓATCCÉÏÂòµÄ£¬»¹ÒªËµÃ÷ʲôÂðÇó´óÉñÖ¸½Ì
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

zjutboss

Òø³æ (СÓÐÃûÆø)

ÇëÎÊÂ¥Ö÷£¬ÄúµÄµÀµÂÉùÃ÷ÔõôдµÄ£¬ÄÜ·ñÌṩ¸øÎÒ£¬ÎÒÒ²ÊÇͶ¸åÐèÒª£¬µ«²»ÖªµÀÔõôд
2Â¥2015-02-06 14:13:05
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ ѧԱJrkt9B µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 281Çóµ÷¼Á£¨0805£© +12 ÑÌÏ«Ò亣 2026-03-16 23/1150 2026-03-20 12:50 by ¹¦·ò·è¿ñ
[¿¼ÑÐ] 274Çóµ÷¼Á +8 S.H1 2026-03-18 8/400 2026-03-20 11:53 by ѧԱ8dgXkO
[¿¼ÑÐ] Ò»Ö¾Ô¸Î÷ÄϽ»Í¨ ר˶ ²ÄÁÏ355 ±¾¿ÆË«·Ç Çóµ÷¼Á +4 Î÷ÄϽ»Í¨×¨²Ä355 2026-03-19 4/200 2026-03-20 11:39 by »¨¿ª¸»¹óÐÒ¸£ÈËÉ
[¿¼ÑÐ] 286·ÖÈ˹¤ÖÇÄÜרҵÇëÇóµ÷¼ÁÔ¸Òâ¿ç¿¼£¡ +3 lemonzzn 2026-03-17 4/200 2026-03-20 11:04 by lemonzzn
[¿¼ÑÐ] Ò»Ö¾Ô¸Î人Àí¹¤²ÄÁϹ¤³Ìר˶µ÷¼Á +7 Doleres 2026-03-19 7/350 2026-03-20 10:39 by EBSD
[¿¼ÑÐ] ÄÜÔ´²ÄÁÏ»¯Ñ§¿ÎÌâ×éÕÐÊÕ˶ʿÑо¿Éú8-10Ãû +5 ÍÑÓ±¶ø³ö 2026-03-16 14/700 2026-03-20 09:30 by kkcoco25
[¿¼²©] É격26Äê +3 °Ë6°Ë68 2026-03-19 3/150 2026-03-19 19:43 by nxgogo
[¿¼ÑÐ] 321Çóµ÷¼Á +8 ºÎÈó²É123 2026-03-18 10/500 2026-03-19 16:46 by ºÎÈó²É123
[¿¼ÑÐ] 328Çóµ÷¼Á£¬Ó¢ÓïÁù¼¶551£¬ÓпÆÑо­Àú +4 ÉúÎ﹤³Ìµ÷¼Á 2026-03-16 12/600 2026-03-19 11:10 by ÉúÎ﹤³Ìµ÷¼Á
[¿¼ÑÐ] 311Çóµ÷¼Á +4 ¶¬Ê®Èý 2026-03-18 4/200 2026-03-18 21:47 by ¾¡Ë´Ò¢1
[¿¼ÑÐ] 354Çóµ÷¼Á +4 Tyoumou 2026-03-18 7/350 2026-03-18 21:45 by Tyoumou
[¿¼ÑÐ] 268Çóµ÷¼Á +8 Ò»¶¨ÓÐѧÉÏ- 2026-03-14 9/450 2026-03-17 17:47 by laoshidan
[¿¼ÑÐ] 275Çóµ÷¼Á +4 Ì«Ñô»¨ÌìÌ쿪ÐÄ 2026-03-16 4/200 2026-03-17 10:53 by ¹¦·ò·è¿ñ
[¿¼ÑÐ] 11408 Ò»Ö¾Ô¸Î÷µç£¬277·ÖÇóµ÷¼Á +3 zhouzhen654 2026-03-16 3/150 2026-03-17 07:03 by laoshidan
[¿¼ÑÐ] ¶«ÄÏ´óѧ364Çóµ÷¼Á +5 JasonYuiui 2026-03-15 5/250 2026-03-16 21:28 by ľ¹Ï¸à
[¿¼ÑÐ] Ò»Ö¾Ô¸211 0703·½Ïò310·ÖÇóµ÷¼Á +3 ŬÁ¦·Ü¶·112 2026-03-15 3/150 2026-03-16 16:44 by houyaoxu
[¿¼ÑÐ] 326Çóµ÷¼Á +3 mlpqaz03 2026-03-15 3/150 2026-03-16 07:33 by Iveryant
[¿¼ÑÐ] 288Çóµ÷¼Á +4 Ææµã0314 2026-03-14 4/200 2026-03-14 23:04 by JourneyLucky
[¿¼ÑÐ] Ò»Ö¾Ô¸¹þ¹¤´ó²ÄÁÏ324·ÖÇóµ÷¼Á +5 ãÆÐñ¶« 2026-03-14 5/250 2026-03-14 14:53 by ľ¹Ï¸à
[¿¼ÑÐ] 311Çóµ÷¼Á +3 ¶¬Ê®Èý 2026-03-13 3/150 2026-03-13 20:41 by JourneyLucky
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û